FSSAI Advisory On Raising Grievances Related To Central Licences’ Plea

New Delhi : The FSSAI has issued an advisory explaining the matrix for raising grievances/queries related to Central licences’ applications.

The advisory says that in case any food business operator (FBO) is aggrieved by the decision by the Central licensing authority, the matter can be escalated to the concerned Regional Director while in case the FBO further wants to represent the case after receiving comments from the concerned Regional Director or in case no comments was received within 21 days from raising the request to the concerned RD, the FBO can escalate the matter before Executive Director Compliance Strategy at FSSAI Headquarters along with all the relevant communication made with respect to the case till date.

The FSSAI has also advised that communication should be made through registered email id as provided in the licensing application by the FBO.

It is pertinent to note that FSSAI has an online platform, the Food Safety Compliance System (FoSCoS) for issuance of pan-India FSSAI licence and registration and for Central licensing procedures as laid down under the FSS Act, the food authority has approved Central Licensing Authority (CLA).

  • Related Posts

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    The Maharashtra Food and Drug Administration (FDA) seized 3,098.46 tonnes of food stock worth Rs 63.45 crore and suspended 954 food licences during a statewide enforcement drive in the past…

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    6-year data disclosed first time by Indian Pharmacopoeia Commission on CIC order The Indian Pharmacopoeia Commission (IPC) has, for the first time, disclosed the number of Serious Adverse Events (SAEs)…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Medicines that cure Us are making Our Environment Sick

    Medicines that cure Us are making Our Environment Sick